Williams Jones Wealth Management, LLC.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1788587
New York, NY
Position in VRTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$506,822
-$16,808 QoQ
Shares Held
1,135
-1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Williams Jones Wealth Management, LLC. holds $1,345,606 across 7 Biotechnology names. VRTX ranks #2 (37.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
810 | $625,838 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,135 | $506,822 | |
| 3 | LCTX |
Lineage Cell Therapeutics, Inc.
|
101,300 | $160,054 | |
| 4 | ATAI |
AtaiBeckley Inc.
|
10,000 | $35,400 | |
| 5 | CYDY |
CytoDyn Inc.
|
45,001 | $12,150 | |
| 6 | NWBO |
Northwest Biotherapeutics Inc
|
25,000 | $5,250 | |
| 7 | PKTX |
ProtoKinetix, Inc.
|
20,000 | $92 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $506,822 | 1,135 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $523,630 | 1,155 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $444,119 | 1,134 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $504,856 | 1,134 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $549,785 | 1,134 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $456,661 | 1,134 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $527,865 | 1,135 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $539,496 | 1,151 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $476,949 | 1,141 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $423,572 | 1,041 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $361,997 | 1,041 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $365,986 | 1,040 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $327,672 | 1,040 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $300,908 | 1,042 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $301,121 | 1,040 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $289,116 | 1,026 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $272,974 | 1,046 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $217,404 | 990 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $777,437 | 4,286 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,143,040 | 5,669 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,409,113 | 20,518 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,230,867 | 26,364 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,749,720 | 54,203 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $939,152 | 3,235 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $300,768 | 1,264 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||